Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous mesenchymal stem cell transplantation in active multiple sclerosis
2009-016442-74Phase 2Active
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Dec 2009
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of autologous mesenchymal stem cells in multiple sclerosis (MS) (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Number of adverse events by toxicity category. Started Dec 2009; status: active.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2009-016442-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016442-74.